FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Manufacturer

Country

Certificates

FDA

Document

No Title 0.2 MB
Registration Date 18 Jan 2015
Share

Visudyne®

(0)

Medicine Pharmaceuticals

Photosensitizing Agent

Drug Information

Generic
verteporfin
Drug Class
Ophthalmologicals
Therapeutic Class
Photosensitizing AgenT
Dosage form
Powder
Route of Administration
Intravenous Injection
Therapeutic Area
1.Photodynamic therapy for age- related macular degeneration 2.Myopia 3.Degenerative Macular Degeneration

Nanomaterials

Liposome

Nanoliposome

Indication

"The first step is the intravenous infusion of Visudyne. The second step is the activation of Visudyne with light from a nonthermal diode laser (Visudyne (verteporfin for injection) is indicated for the treatment of predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia, or presumed ocular histoplasmosis.)"